CCN2 plays a key role in extracellular matrix gene expression in severe hypertrophic cardiomyopathy and heart failure.
about
RhoA Ambivalently Controls Prominent Myofibroblast Characteritics by Involving Distinct Signaling RoutesPatients with encapsulating peritoneal sclerosis have increased peritoneal expression of connective tissue growth factor (CCN2), transforming growth factor-β1, and vascular endothelial growth factor.Genetic Analysis of Connective Tissue Growth Factor as an Effector of Transforming Growth Factor β Signaling and Cardiac Remodeling.Connective tissue growth factor regulates cardiac function and tissue remodeling in a mouse model of dilated cardiomyopathyBalanced regulation of the CCN family of matricellular proteins: a novel approach to the prevention and treatment of fibrosis and cancer.Downregulation of GSTK1 Is a Common Mechanism Underlying Hypertrophic Cardiomyopathy.Molecular control of vascular development by the matricellular proteins CCN1 (Cyr61) and CCN2 (CTGF).Regulation of cellular redox signaling by matricellular proteins in vascular biology, immunology, and cancerIdentification of candidate biomarkers for epithelial ovarian cancer metastasis using microarray data.Regulation and bioactivity of the CCN family of genes and proteins in obesity and diabetes.Networks of blood proteins in the neuroimmunology of schizophrenia.In Silico Analysis of Differential Gene Expression in Three Common Rat Models of Diastolic Dysfunction.Role of double knockdown of tPA and MMP-9 on regulating the left ventricular function and remodeling followed by transverse aortic constriction-induced hypertrophic cardiomyopathy in miceIdentification of target genes in cardiomyopathy with fibrosis and cardiac remodeling
P2860
Q27318689-F47B6CDA-349E-4B32-9A2D-14CFBCAF90CDQ34482573-9240140D-E3B0-4B8B-B18C-23D13FEA0D49Q35626083-E6D55BA1-AD3F-4337-A163-174135F11A04Q36399795-E9634F34-5E67-4C5A-AA5E-00539A3B5F99Q36470970-075E94A6-8404-4A98-AC9E-A6A6C6B574B5Q36999686-EBC7E9D8-96AF-4EAB-9FFD-89FAB1045ABBQ37707888-911F78A5-7B92-4C82-9802-4E4FC721EB26Q38656989-67FE7D13-24B6-4884-A84B-11A8EA3BE3F7Q41701842-4676FC39-5DFC-4232-879F-147C354FF9FCQ50145564-78DE0997-88A9-4214-924C-7D354067E279Q54944546-42B1C93C-E6D7-47CB-90C0-CEB1946B3DCDQ54963943-D0E780C9-2CD9-431F-B330-2AB05EFA11D1Q57493390-8E0F87DB-2826-4478-AE6E-12F7B7DFF7AAQ58775408-2DCCA447-32CC-4BD6-903A-71A3A68BEDE3
P2860
CCN2 plays a key role in extracellular matrix gene expression in severe hypertrophic cardiomyopathy and heart failure.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
CCN2 plays a key role in extra ...... diomyopathy and heart failure.
@en
CCN2 plays a key role in extra ...... diomyopathy and heart failure.
@nl
type
label
CCN2 plays a key role in extra ...... diomyopathy and heart failure.
@en
CCN2 plays a key role in extra ...... diomyopathy and heart failure.
@nl
prefLabel
CCN2 plays a key role in extra ...... diomyopathy and heart failure.
@en
CCN2 plays a key role in extra ...... diomyopathy and heart failure.
@nl
P2093
P1476
CCN2 plays a key role in extra ...... diomyopathy and heart failure.
@en
P2093
Bruce Riser
Kendra Garchow
Stephen Twigg
Tatiana Tsoutsman
Xiaoyu Wang
P304
P356
10.1016/J.YJMCC.2013.05.019
P577
2013-06-10T00:00:00Z